Acrobiosystems Co.,ltd.
Summary
Revenue :
65.01 M USD
Finance :
292.05 M
USD
Earning Cap :
68,765.74
USD / Person
Invest :
0.69 M
USD
R & D :
122 People
Growth :
61.44% AGR
DIGDAL CAP
A
| Developing Status: |
|---|
| Strategy Pattern: |
| Developing Pattern: |
| Strategy Direction: |
| Aggressive | Consertive | Stable |
| Expand | Drawback | Keep |
| Investment | Organic | Default |
| Barrier | Technology Leading | Marketing Leading |
Overview
| General Introduction | ACROBiosystemsGroup (stock code: 301080), a multinational biotechnology company established in 2010, is an industry platform based enterprise that provides key biological reagent products and solutions for the global biopharmaceutical and health industries. Listed on the ChiNext in 2021. Pepsius Group's business is spread worldwide, spanning Asia, North America, and Europe. It has offices, research and development centers, and production bases in 12 cities including China, the United States, and Switzerland. At present, we have served over 7000 customers and established long-term and stable partnerships with top 20 pharmaceutical companies worldwide. The group owns brands such as ACROBiosystems, BioSeedin, CondenseCapital, and ACRODiagnostics, among others. ACROBiosystems includes membrane masterpieces, StarStaining, Aneuro, ComboX, ActiveMax, GENPower, and other sub brands. Its main products and services include proteins, antibodies, test kits, and analysis and testing services, which are applied to drug screening and optimization, preclinical and clinical trials, drug production process and process control (CMC) for diseases such as tumors, autoimmune diseases, cardiovascular diseases, infectious diseases, and neurological diseases Development and optimization of diagnostic reagents and other research and production processes. ACROBiosystems Group, with the mission of accelerating the research and marketing process of biopharmaceuticals and serving better clinical applications, is willing to use its own efforts to create value for the entire industry in the global market, starting from bringing value to customers. The company continuously updates its technology, products, and services, actively empowers its partners, to accelerate the development of targeted drugs and immunotherapy drugs, The research and marketing process of various biopharmaceuticals and their better clinical applications will ultimately contribute to the cause of human health. |
| General Industry | Medical Biology |
| Concepts Industry | |
| Competition Industry | |
| Headquarter | Beijing |
| Employees | 397 |
| Establish Date | 7/22/2010 |
| Ownership | Private Enterprise |
| Listed Code | 301080.SZ |
| Listed Date | 10/18/2021 |
| Chairman | Chen Yiding. |
| CEO | Chen Yiding. |
| Website | www.acrobiosystems.cn |
| IR@acrobiosystems.com | |
| Phone Call | 010-53681107,010-53395173 |
Product
Undisclosed
R & D
TECHNICIANS:
122 People
PATENTS :
24 PCS
R&D / REVENUE :
15.47%
NATIONAL R&D CENTER :
No
NATIONAL STANDARD MAKER :
No
Financial
REVENUE :
65.01 M USD
5 years Revenue performance & ARG
NET EARNING :
27.3 M USD
5 years Profits performance & ARG
Product Business Chart
Undisclosed
Financial Investment
INVESTMENT AMOUNT :
0.69 M USD
INVESTMENT CASES :
1
FINANCE :
292.05 M USD
GLOBAL INVEST :
No
Historical Investment
| Year | Target | Industry | Type | Amount |
|---|---|---|---|---|
| 2022 | Tianjin Kangcheng Baien Equity Investment Fund Partnership (Limited partnership). | Capital Market Services | Foreign Investment | CNY 50.00 M |
Clients & Competitors
Clients
Undisclosed
Competitors
Undisclosed
Industry Research
| Name | Category |
|---|---|
| Medical Biology | General Industry |
Video
Undisclosed
News
Undisclosed
Deep Insights
Deep Insights provide full content of detail of the the Company including legal, financial, strategy, operation and other aspect of the information. These information give a full support and insights for the decision maker, lawyer, financial adviser, consultant, investor and authority to better understand the company before engaging into collaboration, investment, and other operation. We provide these Deep insights service to all the member and the report would be prepared by our analyst and deliver to the member mailbox.
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
